BIIB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BIIB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-28), Biogen's current share price is $208.90. Biogen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $79.21. Biogen's Cyclically Adjusted PB Ratio for today is 2.64.
The historical rank and industry rank for Biogen's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Biogen's highest Cyclically Adjusted PB Ratio was 16.44. The lowest was 2.45. And the median was 7.46.
BIIB's Cyclically Adjusted PB Ratio is ranked worse thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Biogen's adjusted book value per share data for the three months ended in Mar. 2024 was $105.062. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $79.21 for the trailing ten years ended in Mar. 2024.
The historical data trend for Biogen's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogen Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 3.83 | 3.81 | 3.35 | 3.32 | 2.72 |
For the Drug Manufacturers - General subindustry, Biogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Biogen's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Biogen's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Biogen's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 208.90 | / | 79.21 | |
= | 2.64 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Biogen's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 105.062 | / | 129.4194 | * | 129.4194 | |
= | 105.062 |
Current CPI (Mar. 2024) = 129.4194.
Biogen Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 40.489 | 100.560 | 52.109 |
201409 | 44.156 | 100.428 | 56.903 |
201412 | 46.081 | 99.070 | 60.198 |
201503 | 49.597 | 99.621 | 64.432 |
201506 | 53.462 | 100.684 | 68.720 |
201509 | 47.432 | 100.392 | 61.147 |
201512 | 42.876 | 99.792 | 55.605 |
201603 | 47.143 | 100.470 | 60.727 |
201606 | 52.043 | 101.688 | 66.236 |
201609 | 55.694 | 101.861 | 70.762 |
201612 | 56.204 | 101.863 | 71.409 |
201703 | 53.640 | 102.862 | 67.489 |
201706 | 54.794 | 103.349 | 68.616 |
201709 | 60.813 | 104.136 | 75.578 |
201712 | 59.635 | 104.011 | 74.203 |
201803 | 66.603 | 105.290 | 81.867 |
201806 | 60.865 | 106.317 | 74.091 |
201809 | 68.326 | 106.507 | 83.025 |
201812 | 66.124 | 105.998 | 80.735 |
201903 | 70.850 | 107.251 | 85.495 |
201906 | 70.091 | 108.070 | 83.938 |
201909 | 76.943 | 108.329 | 91.923 |
201912 | 76.597 | 108.420 | 91.433 |
202003 | 74.996 | 108.902 | 89.126 |
202006 | 71.438 | 108.767 | 85.002 |
202009 | 69.906 | 109.815 | 82.386 |
202012 | 70.212 | 109.897 | 82.685 |
202103 | 70.931 | 111.754 | 82.143 |
202106 | 72.112 | 114.631 | 81.415 |
202109 | 71.000 | 115.734 | 79.395 |
202112 | 74.124 | 117.630 | 81.553 |
202203 | 76.219 | 121.301 | 81.320 |
202206 | 81.767 | 125.017 | 84.647 |
202209 | 88.719 | 125.227 | 91.690 |
202212 | 93.041 | 125.222 | 96.160 |
202303 | 95.280 | 127.348 | 96.830 |
202306 | 99.910 | 128.729 | 100.446 |
202309 | 99.957 | 129.860 | 99.618 |
202312 | 102.135 | 129.419 | 102.135 |
202403 | 105.062 | 129.419 | 105.062 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Biogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Priya Singhal | officer: Head of Development | C/O ZAFGEN, INC., 175 PORTLAND STREET 4TH FL, BOSTON MA 02114 |
Jane Grogan | officer: Head of Research | BIOGEN INC., 225 BINNEY STREET, CAMBRIDGE MA 02142 |
Susan Langer | director | BIOGEN INC., 225 BINNEY STREET, CAMBRIDGE MA 02142 |
Ginger Gregory | officer: EVP, Human Resources | C/O BIOGEN INC., 225 BINNEY ST., CAMBRIDGE MA 02142 |
Adam Keeney | officer: Head of Corporate Development | BIOGEN INC., 225 BINNEY STREET, CAMBRIDGE MA 02142 |
Christopher Viehbacher | director, officer: President and CEO | C/O AXCELLA HEALTH, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Susan H Alexander | officer: EVP, General Counsel | C/O BIOGEN IDEC INC., 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Nicole Murphy | officer: Head of Pharm Ops and Tech | BIOGEN INC., 225 BINNEY STREET, CAMBRIDGE MA 02142 |
Rachid Izzar | officer: Head of Alzheimer's Disease | BIOGEN INC., 225 BINNEY STREET, CAMBRIDGE MA 02142 |
Chirfi Guindo | officer: EVP Glob. Mkt Acc & Cust Innov | C/O BIOGEN INC., 225 BINNEY ST., CAMBRIDGE MA 02142 |
Alfred Sandrock | officer: Grp SVP, Chief Medical Officer | 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Brian S Posner | director | 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Jones William D /ca/ | director | |
Maria C Freire | director | C/O ALEXANDRIA REAL ESTATE EQUITIES, INC, 26 NORTH EUCLID AVENUE, PASADENA CA 91101 |
Jesus B Mantas | director | BIOGEN INC., 225 BINNEY STREET, CAMBRIDGE MA 02142 |
From GuruFocus
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024